文献速递冠心病外科

射血分数降低患者PCI与CABG的远期结局比较

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-09-16

本研究纳入2011至2018年匹兹堡大学医学中心术前射血分数低于50%并接受血运重建的2000例患者,经倾向性匹配1:1后每组324例,比较PCI与CABG的远期生存、再入院及MACCE,结果显示CABG组生存更优、MACCE更少。

要点

  • 射血分数降低患者中,CABG较PCI显著改善远期生存
  • CABG组MACCE、再入院及再次血运重建均少于PCI组

核心结论

  • 射血分数降低患者接受CABG较PCI显著改善生存、降低MACCE并减少再次血运重建。

研究设计与样本

  • 回顾性队列研究,纳入2011至2018年单中心术前射血分数低于50%并接受CABG或PCI的血运重建患者共2000例,CABG组1553例、PCI组447例。
  • 采用倾向性匹配1:1校正基线特征,匹配后每组324例,平均射血分数35%±9.53%。

主要发现

  • 随访中位3.23年(范围1.83-4.98年)总死亡率PCI组显著更高(37.4% vs 21.3%;P < .001)。
  • PCI组总再入院(24.1% vs 12.9%;P = .001)、心脏再入院(20.4% vs 11.1%;P = .001)、心肌梗死事件(7.7% vs 1.8%;P = .001)、MACCE(41.4% vs 23.8%;P < .001)及再次血运重建(6.5% vs 2.6%;P = .02)均更频繁。
  • PCI组1年(74.4% vs 87.0%;P < .001)和5年(54.5% vs 74.0%;P < .001)无MACCE生存率显著更低。
  • 多因素Cox回归显示CABG与生存改善显著相关(HR 0.57;95%CI 0.44-0.73;P < .001),再入院(HR 0.51;95%CI 0.37-0.71;P < .001)和MACCE(HR 0.48;95%CI 0.39-0.58;P < .001)风险更低。

临床怎么用

  • 对射血分数降低(低于50%)的冠心病患者,CABG在远期生存和MACCE方面优于PCI,决策时应优先考虑CABG。
  • 术前肝病、透析、糖尿病和外周动脉疾病是死亡的最显著预测因素,可用于风险分层。

局限性

  • 本研究为单中心回顾性队列,尽管采用倾向性匹配,仍可能存在未测量混杂。
  • 原文未报告匹配后队列的具体随访时间及其他潜在局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate comparative outcomes for percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in patients with reduced ejection fraction. METHODS: All patients from the University of Pittsburgh Medical Center from 2011 to 2018 who had reduced preoperative ejection fraction (<50%) and underwent CABG or PCI for coronary revascularization were included in this study. Patients were risk-adjusted with propensity matching (1:1) and primary outcomes included long-term survival, readmission, and major adverse cardiac and cerebrovascular events (MACCE). RESULTS: A total of 2000 patients were included in the current study, consisting of CABG (n = 1553) and PCI (n = 447) cohorts with a mean ejection fraction of 35% ± 9.53%. Propensity matching yielded a 1:1 match with 324 patients in each cohort, controlling for all baseline characteristics. Thirty-day mortality was similar for PCI versus CABG (6.2% vs 4.9%; P = .49). Overall mortality over the study follow-up period (median, 3.23 years; range, 1.83-4.98 years) was significantly higher for the PCI cohort (37.4% vs 21.3%; P < .001). Total hospital readmissions (24.1% vs 12.9%; P = .001), cardiac readmissions (20.4% vs 11.1%; P = .001), myocardial infarction event (7.7% vs 1.8%; P = .001), MACCE (41.4% vs 23.8%; P < .001), and repeat revascularization (6.5% vs 2.6%; P = .02) occurred more frequently in the PCI cohort. Freedom from MACCE at 1 year (74.4% vs 87.0%; P < .001) and 5 years (54.5% vs 74.0%; P < .001) was significantly lower for the PCI cohort. On multivariable cox regression analysis, CABG (hazard ratio, 0.57; 95% confidence interval, 0.44-0.73; P < .001) was significantly associated with improved survival. Prior liver disease, dialysis, diabetes, and peripheral artery disease were the most significant predictors of mortality. The cumulative incidence of hospital readmission was lower for the CABG cohort (hazard ratio, 0.51; 95% confidence interval, 0.37-0.71; P < .001). Multivariable cox regression for MACCE (hazard ratio, 0.48; 95% confidence interval, 0.39-0.58; P < .001) showed significantly fewer events for the CABG cohort. CONCLUSIONS: Patients with reduced ejection fraction who underwent CABG had significantly improved survival, lower MACCE, and fewer repeat revascularization procedures compared with patients who underwent PCI.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bianco V, Kilic A, Mulukutla S, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction. J Thorac Cardiovasc Surg. 2020. PMID: 33059935. doi:10.1016/j.jtcvs.2020.06.159

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。